Looking beyond MHDs when assessing the burden of migraine

Sponsored by Eli Lilly Australia Pty Ltd

After estimating that migraines lead to tens of billions of dollars in lost productivity in Australia, the authors of a health and productivity analysis concluded that funding towards reducing the prevalence and effects of migraine is likely to be “a sound return on investment.”1  Neurologists now have further options available for patients in whom migraine ...

Already a member?

Login to keep reading.

© 2021 the limbic